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Abstract The present work reports on the quantification of
total IgE in human serum using a microanalytical device
whose fluidics is driven by gravity and capillary forces
only. Thanks to the eight parallel microchannels in each
microchip, calibration and sample analysis are performed
simultaneously. A mixture of magnetic bead/analyte/second
antibody is incubated off-line and then percolated through
the channels where magnetic beads are trapped, enabling
the separation of the solid phase from the excess reagents.
The entire assay is performed in less than 1 h, and thanks to
the miniaturized format, only a small volume of serum is
required. Non-specific adsorption was first investigated and
a blocking agent compatible with this allergy-based test
was chosen. Then, the assay was optimized by determining
the best magnetic bead and labelled antibody concentra-
tions. After achievement of a calibration curve with a
reference material, the protocol was applied to total IgE
quantification of a patient serum sample that showed results
in good accordance with those obtained by ImmunoCap®
and Immunoaffinity capillary electrophoresis measure-
ments. A detection limit of 17.5 ng ml−1 was achieved
and good reproducibility (RSD<10%) inter- and intra-chip
was observed.
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Introduction
A major health issue today concerns allergic diseases that
are estimated to affect 20% of the population [1]. Diseases
such as allergic rhinitis, asthma and atopic eczema are
increasing in prevalence and it has been suggested that this
trend may be due to the sanitized Western lifestyle
depriving the immune system of molecules helping its
development and the extensive use of antibiotics [2].
Allergy is an abnormal immunoglobulin E (IgE) mediated
immune reaction to normally harmless environmental
substances and is also called immediate or type I
hypersensitivity [1]. Briefly, the sequence of events in the
development of immediate hypersensitivity reactions con-
sists of a first exposure to the allergen resulting in the
activation of TH2 cells. By secreting cytokines, the latter
stimulate B cells specific for the foreign antigen to
transform into IgE-producing cells. The IgE antibodies
produced bind to specific receptors of mast cells, sensitizing
them. The next encounter with the foreign antigen leads to its
recognition by the activated mast cells and to secretion of
proinflammatory mediators, such as histamine, causing
immediate symptoms [1, 3].
The diagnosis of allergy can be confirmed by either in
vivo or in vitro methods. Skin tests where a commercial
allergen extract droplet is placed on the skin before
abrading the skin with a needle are a particularly useful in
vivo tool, but can be contraindicated, as in some cases,
anaphylactic reactions may occur [4]. In vitro methods
imply mainly the use of ELISA-related techniques, even if
flow cytometric quantification of in vitro basophile activa-
tion can be reliable [4]. An allergy immunoassay involves
the quantification of IgE in serum, either total IgE testing to
confirm that the allergy is atopic or specific IgE to identify
the allergen(s) responsible for the disease [5]. Total IgE
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serum levels vary during the lifetime, being <1 kIU/l at
birth [5] (1 IU=2.4 ng), reaching its highest levels at age
15–20 and remaining constant until about an age of 60,
when it slowly declines [6]. Three immunoassay systems
capable of quantifying total and specific IgE are commer-
cially available: the HYTEC™ 288 from Hycor, the
ImmunoCAP® from Phadia and the Immulite® from
Siemens. These three systems provide similar analytical
sensitivities (0.1 kIU l−1) and make use of a sandwich
immunoassay with detection through enzyme-labelled anti-
IgE [7]. However, even if these commercial systems offer
suitable sensitivities, low detection limits, high throughput
and automation, they are relatively expensive and time and
sample/reagent consuming. Indeed, an ImmunoCap assay is
performed within 3 h [8] and requires about 40 μl of serum
for total IgE quantitation. As a consequence, research now
focuses on the reduction of both assay time and sample/
reagent consumption.
Ten years ago, an immunosensor using disposable
screen-printed carbon electrodes and amperometric detec-
tion was developed to carry out IgE quantitation in 30 min
with a detection limit of 0.09 ng ml−1 [9]. The same type of
electrodes was used later by the same group to carry out a
competitive assay where the detection was carried out by
differential pulse voltammetry [6]. Instead of using an anti-
IgE antibody to recognize the target IgE, an aptamer was
chosen with the advantage of being insensitive to temper-
ature and low cost. These interesting features explain the
number of publications concerning IgE quantification with
aptamers [10–13]. Other studies were also carried out,
making use of surface plasmon resonance spectroscopy [14,
15] and quartz crystal microbalance detection [15]. In the
microchip field, a micro-ELISA was performed on polysty-
rene beads achieving a detection limit of 2 ng ml−1 with
thermal lens microscope detection [16]. Another strategy
used the competition between IgE to be quantified and IgE-
sensitized immunoliposomes entrapping a fluorescent dye
for anti-IgE immobilized on a nitrocellulose membrane
[17]. In addition, a number of publications concern IgE
quantification with magnetic beads with the advantage of
increasing the specific surface for reaction, being easily
trapped by permanent magnets and having a large choice of
functionalizations commercially available [18]. Among
these studies, an optical detection method based on the
deflection of magnetic particles caused by a magnetic field
gradient was used to analyse allergen-specific IgE for
Dermatophagoides farinae and Dermatophagoides ptero-
nyssinus in patient serum, with detection limits of 565 and
268 fM respectively [19]. An immunoassay, with an anti-
IgE antibody grafted on magnetic beads and IgE-specific
aptamers attached to polystyrene beads as label for
chemiluminescent detection was developed to detect IgE
down to 4.6 pM [20]. Finally, a capillary electrophoresis
system using fluorescence detection was developed in our
lab with a sensitivity in the low picomolar range and a
highly linear dynamic range from 2.4 to 2,400 ng ml−1 [21].
In this work, a sandwich-type immunoassay using
magnetic beads was developed for total IgE quantification
in serum using a commercial device, the GRAVI™-Cell
from DiagnoSwiss, having the particular feature of working
with gravity and capillary force-driven fluidics only.
Gravity-induced flows are not commonly used to perform
immunoassays, but the concept was demonstrated in
previous studies, first by coating the whole microchannel
with antibodies [22], before using magnetic beads as a solid
support [23]. More recently, this system was used to detect
specific DNA sequences of Legionella pneumophila, with a
RSD of 8.5% and a detection limit of 0.33 nM [24]. In this
work, non-specific adsorption was first studied and after
testing different blocking solutions, the most adequate one
was chosen to limit non-specific adsorption. Then, the
assay was optimized by determining the best magnetic bead
and labelled antibody concentrations. After achievement of
a calibration curve with a reference material, the protocol
was applied to total IgE quantification of a patient serum
sample whose concentration was previously determined by
an ImmunoAffinity Capillary Method developed in our lab
[21] and by classical ImmunoCap® method.
Material and methods
Chemicals
Mouse anti-human IgE recognizing an epitope expressed on
the Cε3 domain (0100–0414) and an epitope expressed on
the Cε2 domain (0100–0413) respectively was purchased
from AbD Serotec (Oxford, UK). Reference human IgE
was obtained from the National Institute for Biological
Standards and Control. Alkaline phosphatase with an
activity between 2,000 and 4,000 Umg−1 protein, gelatin
from porcine skin, bovine serum albumin (BSA), human
serum albumin (HSA) and Tween 20 was from Sigma.
Dimethyl sulfoxide (DMSO) was purchased from Fluka.
The enzyme substrate, para-aminophenyl phosphate
(PAPP), was obtained from DiagnoSwiss (Monthey,
Switzerland). Tosyl-activated Dynabeads® MyOne™
(1.08 μm in diameter) were from Invitrogen (Oslo,
Norway).
All the buffers and sample solutions were prepared with
water produced by an alpha Q Millipore System (Zug,
Switzerland).
Buffers had the following composition: blocking buffer
(phosphate buffer saline (PBS) pH 7.4 containing 0.05%
Tween 20 and 0.5% gelatin), washing buffer (PBS pH 7.4
containing 0.05% Tween 20) and substrate solution for
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electrochemical reaction (PAPP 10 mM in 100 mM Tris
buffer, pH 9.8).
Apparatus
All the assays were carried out with the GRAVI™-Cell
immunoassay device from DiagnoSwiss (Monthey,
Switzerland). The instrument is used with polyimide
GRAVI™-Chips that are composed of eight independent
microchannels allowing the performance of eight tests in
parallel. The chips are reusable if the microchannels are
washed carefully after each experiment. Each microchannel,
which is 1.5 cm in length and has a cross-section of 90×
200 μm2, possesses two 30 μl reservoirs, at the inlet and
outlet of the channel respectively. The distance between two
microchannels, 9 mm, was defined to provide compatibility
with standard microtitreplates. Electrochemical detection
occurs directly in the chip thanks to integrated micro-
electrodes. As indicated by its name, the GRAVI™-Cell is
a device in which liquid flows are driven by gravity and
capillary forces only, as the chips are fixed to a surface tilted
at 30°. An array of eight permanent magnets is integrated to
the device and can be easily placed and removed. Data were
acquired and processed with the GRAVI-Soft software. The
different elements are illustrated in Fig. 1.
Grafting mouse anti-human IgE antibody to magnetic beads
Anti-human IgE antibody (0100–0413) was covalently
coupled to tosyl-activated magnetic beads following the
manufacturer’s instructions. An antibody/bead ratio of
40 μg of antibody for 1 mg of beads is generally
recommended for an optimal conjugation reaction. A 10-
μl volume of beads (100 mg ml−1) was first washed three
times with 100 μl of coating buffer (sodium borate buffer,
100 mM, pH 9.5) and then resuspended in 87 μl of the
same buffer. Then, 40 μl of anti-human IgE antibody
(1 mg ml−1) and 83 μl of ammonium sulphate (3 M in
coating buffer) were added. The mixture was incubated for
24 h at 37 °C with slow agitation. Finally, the beads were
washed twice with washing buffer and resuspended in PBS
containing 0.025% of Tween 20 and 0.02% of sodium
azide. Before use, the required amount of magnetic beads
was blocked with blocking buffer overnight at 37 °C with
slow agitation (beads at 1 mg ml−1). The beads were further
diluted in PBS with 0.05% Tween 20. The success of the
grafting was investigated by a CE immunoaffinity method
described by Chen et al. [25]. The grafted magnetic beads
were trapped in the capillary, a standard human IgE
solution was flowed through the capillary and IgE were
captured on the beads. After washing, acidic conditions
were used to release the IgE and detect them.
To get an insight of the amount of antibodies grafted on the
magnetic beads, a BCA protein assay was performed (Pierce,
USA) according to the manufacturer instructions: 1 ml of
working reagent was mixed with 50 μl of sample/beads
followed by a 3-h incubation at room temperature with slow
agitation in order to avoid bead sedimentation. The bead
sample was prepared as follows: 10 μl of beads (5 mg ml−1)
was washed three times and resuspended in 50 μl water.
Absorbance measurements were carried out with a Lambda
XLS+UV/Vis spectrophotometer (PerkinElmer) at 562 nm. A
calibration curve was then determined with 7 standard anti-
human IgE antibody (0100–0413) solutions ranging from 2.5
to 250 μg ml−1 (R2=0.9983). A blank containing non-grafted
tosyl-activated beads was measured and its signal subtracted
from the grafted bead signal. With the data provided by the
bead manufacturer, the number of antibodies per bead and
Γmax were determined to be 1.4857·10
5 Ab bead−1 and
6.738·10−8 mol m−2 respectively.
Fig. 1 (a) GRAVI™-Cell device
with an 8-microchannel chip
tilted at 30°. (b) Cross-section
along a microchannel showing
the trapping of the magnetic
beads. (c) GRAVI™-Chip
comprising eight microchannels
with two lines of reservoirs, at
the inlet (top) and the outlet
(bottom)
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Labelling mouse anti-human IgE antibody with alkaline
phosphatase
Alkaline phosphatase (0.2 mg) was first dissolved in 100 μl
(0.1 mg) of anti-human IgE antibody (0100–0414). An
aqueous solution (5 μl) of glutaraldehyde 1% was then
added to the solution. The mixture was incubated 24 h at
room temperature with slow agitation. Then, 10 μl of
ethanolamine 1 M was added and the solution was left for
2 h incubation at room temperature with slow agitation.
Finally, 115 μl of PBS containing 0.05% of Tween 20 and
0.04% of sodium azide was added.
Immunoassay procedure
The protocol is divided in six main steps:
1. Sample preparation: Four microlitres of antibody
coated magnetic beads was mixed with 10 μl of IgE
(reference solution or diluted serum) and 6 μl of ALP-
labelled antibody. Each solution was at the desired
concentration. The mixture was then incubated for
30 min at room temperature with agitation.
2. Blocking step: If the microchip was used for the first
time, the microchannels were pre-wetted with ethanol
and water. The microchannels were then washed with
PBS containing 0.05% of Tween 20 by loading the
solution into the top reservoirs of the chip. Then, 20 μl
of blocking buffer was percolated by gravity through
the channels for a total duration of 14 min, so as to
block their surface and avoid non-specific adsorption. It
can be noted that this step was carried out during the
sample incubation, avoiding any dead time.
3. Sample dispensing: Fifteen microlitres of the incubated
sample mixture was dispensed in the upper reservoirs
of the microchip. The solution flowed through the
microchannels, while the magnetic beads were trapped
nearby the electrodes by the magnet array.
4. Washing: The upper reservoirs were rinsed three times
with 20 μl of washing buffer and the channels were
washed with 15 μl of the same buffer to eliminate
contaminants and unbound reagents.
5. Substrate addition and electrochemical detection:
Twenty microlitres of PAPP solution was dispensed in
the top reservoirs of the microchip for enzyme-
mediated generation of electrochemical signal.
Alkaline phosphatase hydrolyzes PAPP into the elec-
trochemically active p-aminophenol (PAP). By apply-
ing an oxidizing potential, PAP is then converted into
4-quinonimide (4-QI) and two electrons are produced.
After 1 min, the excess of substrate is removed from
the top reservoirs and the electrochemical signal,
generated by application of a 300-mV potential versus
Ag/AgCl, is measured in static mode during 0.5 s
alternatively in each channel. The measurement was
repeated ten times per channel for a total acquisition
time of 1 min and a plot of the current versus time was
obtained for each channel.
6. Chip regeneration: Once the signal readout was over,
the magnet array was removed. Twenty microlitres of
DMSO was dispensed in the top reservoirs and directly
aspired through the channels by application of a
depression in the bottom reservoirs. This procedure
was repeated three times to denature and eliminate
beads and other reagents from the microchannels.
Finally, reservoirs and channels were washed with
water and PBS containing 0.05% of Tween 20.
Results and discussion
Non-specific adsorption
Adsorption is a pervasive phenomenon, such as in this
work, IgE, anti-IgE or other serum sample components may
adsorb to the microchannel walls or to the magnetic beads.
These non-specific interactions have to be limited, as they
might skew quantitative results. Consequently, it is neces-
sary to block the surfaces to obtain a powerful quantitative
method. Many blocking agents are available and the most
common ones are proteic, such as BSA or casein, but
polymeric coatings, such as poly(vinyl pyrrolidone) (PVP),
are also used [26].
The first step of this study was to reduce the non-specific
adsorption on channel walls by testing four blocking
agents: PVP, HSA, BSA and gelatin. Therefore, channels
were filled with a blocking solution prepared in PBS,
0.05% Tween 20 and left for incubation. A solution of
labelled antibody was then percolated through the channels,
followed by washing and electrochemical detection. Results
obtained with the four blocking agents are presented in
Fig. 2. It can be seen that a high residual signal is obtained
for PVP, meaning that the blocking of the channels is not
efficient. HSA, gelatin and BSA reduce non-specific
adsorption in the same manner and the background signal
is very low relative to the specific signal obtained with the
beads (see Figs. 4 and 5). However, as this study is
dedicated to allergy, it is necessary to take into account the
potential allergenicity of the blocking agent. Milk allergy is
the most frequent food allergy among children, but it is less
frequent in adults [27]. While milk contains around 20
different potentially allergenic proteins, only a few are
recognized as major allergens, notably ß-lactoglobulin and
casein [27]. Allergy to BSA is rare and this protein is
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considered as a minor allergen [28]. Nevertheless, as the
serum quantified in this work comes from a milk allergic
patient and as the exact allergen(s) is unknown, BSA
should not be used as a blocking agent. HSA being an
expensive protein, it was excluded because of its price.
Finally, porcine gelatin was chosen as the blocking agent.
Though, it might also be considered as an allergenic
compound. However, pork meat is very rarely allergenic;
moreover, a recent study conducted on 116 pork meat-
specific IgE positive children showed that only 38% of
them were positive for porcine gelatin-specific IgE [29],
showing how unlikely is an allergy to gelatin. To exclude
any specific reaction between the reference IgE and gelatin,
an experiment consisting in coating the microchannels,
flowing an IgE solution (6,000 ng ml−1 in PBS 0.05%
Tween 20) before percolating the labelled antibody was
performed and no significant signal was observed.
Finally, non-specific adsorption on the magnetic beads
was also investigated. The beads were blocked as described
in the “Material and methods” section. The microchannels
were first blocked with PBS containing 0.05% of Tween 20
and 0.5% of gelatin. Blocked and non-blocked magnetic
beads were incubated with labelled antibody and the
solution was then percolated through the microchannels,
followed by a washing and a detection step. A signal should
be observed only if non-specific interactions occur. The
results showed that the blocking step decreases significantly
the electrochemical signal to 5% of its initial value (from
399.0±50.9 to 22.3±3.2) indicating that blocking the beads
is a necessary step.
Immunoassay optimization
After eliminating all possible sources of non-specific
adsorption, the optimal concentrations of the magnetic
beads and labelled antibody solutions had to be determined
before calculating any calibration curve. To that purpose,
seven reference IgE concentrations were prepared, ranging
from 46.875 to 3,000 ng ml−1. Various concentrations of
each parameter were investigated for all reference IgE
concentrations, keeping the second parameter constant,
providing a “calibration curve” for each parameter value.
The optimal magnetic bead concentration was first
determined by varying its concentration from 0.0125 to
0.4 mg ml−1 and keeping a constant concentration of
labelled antibody, high enough (30 μg ml−1) so as it is not a
limiting factor. It can be observed in Fig. 3 that there is
clear dependence of the current on the bead concentration.
For a given IgE concentration, the signal increases with the
bead concentration up to 0.2 mg ml−1 and a decrease is
observed for 0.4 mg ml−1. It is probably due to the fact that
Fig. 2 Effect of different blocking agents on the non-specific
adsorption on the microchannel walls. The inset is a zoom showing
the lowest signals. Blocking buffers were as follows: PBS 0.05%
Tween 20 with PVP 1% or 2%, HSA 1% or 2%, gelatin 0.5% or 1%
or BSA 2%. Procedure is as follows: (1) loading two times 20 μl of
the blocking solution; (2) incubation: 30 min for PVP solutions,
12 min for HSA and gelatin, 6 min for BSA; (3) loading 20 μl of
labelled antibody 25 μg ml−1; (4) washing and (5) detection
Fig. 3 Signal obtained for different magnetic bead concentrations.
Conditions are as follows: labelled antibody concentration=
30 μg ml−1. (a) 3D plot and (b) 2D plot with the dots representing
the different bead concentrations
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the beads sediment, either in the well or in the channel and
impede the flow through the microchannel. By looking at
the signal for a constant bead concentration, it can be seen
that the signal increases with IgE concentration. However,
for bead concentrations lower than 0.2 mg ml−1, there is a
sudden decrease for the 3,000 ng ml−1 IgE concentration,
certainly due to a high-dose hook effect. Indeed, this effect
occurs only in one-stage sandwich immunoassays, when
the first antibody, antigen and second antibody are
simultaneously mixed. It is due to excessive analyte
concentrations that simultaneously saturate both capture
and detection antibodies, preventing the formation of the
full complex [5]. A way to avoid this undesired effect is to
perform the immunoassay in two steps, and to wash the
excess analyte before adding the labelled antibody. This
would be easy to implement, as magnetic beads can be
isolated with a magnet, but it would also extend the assay
time. Consequently, it was decided in this work to give
priority to assay time and perform a one-step assay
requiring finding conditions where no hook effect occurs.
Concerning the optimal bead concentration, according to
the results, values equal to 0.1 or 0.2 mg ml−1 would be
suitable, as both give high signal. Nevertheless, to
minimize bead and labelled antibody consumption,
0.1 mg ml−1 was chosen for the following experiments,
even if the hook effect observed at 0.1 mg ml−1 decreases
the assay dynamic range.
The concentration of ALP-labelled antibody was then
optimized for a constant 0.1 mg ml−1 bead concentration.
Labelled antibody concentration was varied from 1.875 to
30 μg ml−1 with the same IgE concentration range as
previously. As illustrated in Fig.4, for a given IgE
concentration, the signal increases with the labelled
antibody concentration, but this increase is more pro-
nounced for higher IgE concentrations, while the lowest
tend to saturation. This is certainly due to the low amount
of IgE to bind that is the limiting factor. Consequently,
increasing the concentration of beads is useless, as there are
already too many binding sites for IgE antibodies. Similar
to the magnetic bead optimization, for an identical labelled
antibody concentration, the signal increases with the IgE
concentration, but as already observed before, a decrease
due to a high-dose hook effect is observed for the highest
labelled antibody concentration. However, this effect dis-
appears when the labelled antibody concentration
decreases. It can thus be attributed to the high IgE
concentration, but also certainly to an excess of labelled
antibody relative to the number of binding sites available
on the beads. Indeed, as described by Fernando and Wilson,
the one-step reaction is assumed to reach equilibrium and if
any of the three reactants is present in insufficient or excess
amount, the equilibrium may shift in either direction
causing significant signal deviation from the expected
behaviour [30]. By decreasing the labelled antibody
Fig. 5 Calibration curves for the quantification of total IgE. A linear
response was determined for the logarithm of reference IgE
concentration. Conditions are as follows: magnetic beads
(0.1 mg ml−1) blocked overnight with gelatin 0.5%, labelled antibody
15 μg ml−1
Fig. 4 Signal obtained for different labelled antibody concentrations
(Ab*). Conditions are as follows: bead concentration=0.1 mg ml−1.
(a) 3D plot and (b) 2D plot with the dots representing the different IgE
concentrations
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concentration without modifying that of the beads, the
equilibrium is displaced and no hook effect is observed
anymore. Finally, as all labelled antibody concentrations
lower than 30 μg ml−1 provide curves without hook effect
for this IgE concentration range and consequently a higher
dynamic range, the concentration ensuring the highest
signal, 15 μg ml−1, was chosen for the following experi-
ments. Concerning the sensitivity, the limit of detection
(LOD) depends on background noise, on the presence of
contaminations, on non-specific adsorption, as well as on
the residual oxidation of some assay components, like the
assay biomolecules. As a consequence, increasing the bead
and labelled antibody concentrations may induce a higher
noise, leading to a higher LOD. However, this feature was
not studied in detail in this work.
Calibration curve and application to patient serum sample
With a view of quantifying total IgE in patient serum sample, a
calibration curve was plotted using the optimal bead and
labelled antibody concentrations determined in the previous
section, and the same reference human IgE concentration
range. A linear calibration curve, average of three experiments
performed in the same chip, was obtained for IgE concen-
trations ranging from 46.875 to 3,000 ng ml−1 between the
logarithm of the IgE concentration and the signal (Fig. 5).
Higher concentrations led to a decreased signal, due to the
hook effect described previously. The calibration curve in the
same chip is quite reproducible (RSD=4.2%, n=3). The
assay limit of detection, defined as three times the standard
deviation of the blank, that is to say an assay with a zero IgE
concentration, was determined to be 17.5 ng ml−1 IgE.
The applicability of the method was then demonstrated
through the analysis of a patient serum sample that had
already been quantified by two other methods, ImmunoCap
(performed by the Laboratoire Environnement et Chimie
Analytique in Paris) and an immunoaffinity capillary
electrophoresis method developed in our laboratory [21].
To fully validate the method, more samples should be
analysed, but the goal of this study was to demonstrate the
concept only. To avoid any potential variation due to the
use of different experimental conditions, the calibration
curve and the serum sample were analysed simultaneously
thanks to the eight parallel microchannels of the chip. In the
present case, five calibrators and three dilutions of the
serum sample were tested together. Knowing the total IgE
concentration of the sample previously determined by two
other methods, the sample was diluted 16, 32 and 43 times.
However, in the case of an unknown sample, the dilution
factor could be adapted. Four repetitions were performed on
the same chip, and RSD values of 7.8%, 10.4% and 9.2%
were obtained for dilutions of 16, 32 and 43 respectively.
The average IgE concentration calculated for the three
dilutions is 2,294.3 ng ml−1 and the average RSD is equal
to 9.1%. By comparing these results with those obtained by
other techniques as in Table 1, it can be seen that the
GRAVI™-Cell results are in good agreement.
To evaluate the inter-chip reproducibility of the test, the
sample was then analysed with another chip and different
batches of magnetic beads and labelled antibody. The
calibration curve obtained by the analysis of five calibrators
(46.875, 93.75, 187.5, 375 and 750 ng ml−1) is shown in
Fig. 6, with the three sample dilutions in red. An average
concentration of 2,279.2 ng ml−1 was obtained for the
quantification of total IgE in the serum sample. This result
is in good agreement with that found previously (RSD (IgE
concentration) <1%).
Conclusions
The GRAVI™-Cell technology, where fluids are driven by
gravity and capillary force, was successfully applied to the
quantification of total IgE in human serum. A one-step
sandwich-type ELISA using magnetic beads as a solid
phase for the first antibody was developed. The mixture
bead/analyte/second antibody was incubated off-line and
then percolated through the channels where magnetic beads
were trapped, enabling the separation of the solid phase
Table 1 Comparison of different techniques for the total IgE
quantification in a patient serum sample
IA-CE/LIF
(ng ml−1)
ImmunoCap®
(ng ml−1)
GRAVI™-Cell
(ng ml−1)
IgE concentration 1,994.9 2,610.6 2,294.3
Fig. 6 Calibration curve (black) and signal obtained for three
different dilutions of serum sample (red triangles). All the values
were measured simultaneously in the eight channels of the chip.
Conditions are as follows: magnetic beads (0.1 mg ml−1) blocked
overnight with gelatin 0.5%, labelled antibody 15 μg ml−1
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from the excess reagents. Finally, after washing, electro-
chemical detection was performed.
Firstly, the non-specific adsorption was reduced by
finding a good blocking agent for both microchannels and
beads that had to be compatible with this allergy-based test,
that is to say non potentially allergenic. As the sample
studied here was from a milk-allergic patient, blocking
proteins from milk had to be avoided. However, with other
samples, the blocking agent may be adapted, as allergies to
porcine gelatin are possible. Secondly, the optimal magnetic
bead and labelled antibody concentrations were investigated
by measuring the signal obtained for a range of reference IgE
concentrations. A compromise between minimal reagent
consumption and high-dose hook effect shunning was found.
Finally, calibration curves were measured and their reproduc-
ibility was studied before carrying out the quantification of
one sample that showed results in good accordance with those
obtained by ImmunoCap® and Immunoaffinity CE measure-
ments. Good reproducibility (RSD<10%) inter- and intra-chip
was observed.
Thanks to the eight parallel microchannels in each chip,
calibration and sample analysis can be performed simulta-
neously. In spite of 30 min incubation of the sample with
the beads and secondary antibody, the entire assay can be
performed in less than 1 h, and thanks to the miniaturized
format, only 1.5 μl of serum was required for the sample
studied in this work. Moreover, the platform offers the
possibility to use a robot for mixing the solutions and
transferring the solutions from a microtiterplate, enabling a
fully automated assay.
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